The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells
- Mendez, S.
- Traslavina, R.
- Hinchman, M.
- Huang, L.
- Green, P.
- Cynamon, M.H.
- Welch, J.T.
ISSN: 0066-4804, 1098-6596
Année de publication: 2009
Volumen: 53
Número: 12
Pages: 5114-5121
Type: Article